2013;36:3396C404
2013;36:3396C404. HbA1c in both groupings after empagliflozin treatment (Group 1, p 0.001 and Group2, p=0.001). When the lipid profile was examined, no factor was discovered between basal and post-treatment variables (p 0.05). Sufferers in Group 1 and Group 2 dropped 2.61.2 and 3.82.0 kg of bodyweight, respectively (p 0.0001 for every). There have been also … [Read more…]